Zimmer Biomet Meets Growth Target, Adds Optionality
The company grew in the mid-single digits on a constant currency basis and expanded its technology options for surgeons. Aug 12, 2024
Globus Medical’s Strong Integration Start Leads to Guidance Raise
The company continued its strong performance in the second quarter amid integration efforts and raised 2024 pro forma guidance. Aug 07, 2024
ATEC’s Strong Surgeon Adoption Trends Drive Guidance Raise
The company grew 25% in the second quarter of 2024, taking people and market share from spine's incumbent players. Aug 07, 2024
Vericel’s MACI Sets Second Quarter Revenue Record
The company's MACI sales grew over 20% in the second quarter of 2024 as biopsy rates and conversions ramp up to drive growth. Aug 07, 2024
Smith+Nephew’s Multiyear Transformation Showing Results
The company's orthopedic sale grew in the mid single digits during the second quarter as its transformation plan shows results. Aug 05, 2024
CONMED’s Supply Woes to Last Longer Than Expected
The company's sales declined in the low single digits in the second quarter of 2024 amid a bevy of ongoing supply chain issues. Aug 05, 2024
2024 Orthopedic M&A Trends
Orthopedic M&A activity is on track for a historically low year. We discuss the slowdown, highlight companies making moves and provide an outlook for the remainder of 2024. Aug 02, 2024
Stryker Raises Guidance, Bullish on Sustained Growth
The company's orthopedic sales grew in the high single digits during the second quarter on healthy procedure volume and commercial execution. Jul 31, 2024
Top Orthopedic Companies See Significant International Opportunities
The U.S. remains the world's largest orthopedic market by revenue, but companies see significant opportunities for international growth. Jul 30, 2024
Medacta Outperforms Market Again in First Half of 2024
The company celebrated its 25th anniversary with a world tour of scientific events and continued above-market growth in 2024's first half. Jul 29, 2024
